Can High Preoperative Neutrophil-lymphocyte Ratio Predict the Recurrence and Progression Risk of Nonmuscle- invasive Bladder Tumors?

Journal Title: The Bulletin of Urooncology - Year 2019, Vol 18, Issue 2

Abstract

Objective: Neutrophil-lymphocyte ratio (NLR) is a well-known, cost-effective biomarker of inflammatory conditions, and its protumor effect has been shown in different types of cancers. In this study, we aimed to evaluate the relationship between blood parameters, especially NLR, with the risk of progression and recurrence in non-muscle-invasive bladder tumors (NMIBT). Materials and Methods: Seventy-six patients were included in the study. Patients were divided into low, moderate and high-risk groups according to the risk of progression and recurrence. The preoperative blood parameters of the patients were recorded from the patient files and the NLR of each patient was calculated. These parameters were compared in terms of progression and recurrence risk groups. P values less than 0.05 were accepted statistically significant. Results: Neutrophil-lymphocyte ratio was significantly higher in the high-risk group in both the progression and recurrence risk groups than in the low and moderate risk groups (p<0.001). In addition, according to the post hoc results, the NLR values in the high-moderate and moderate-low risk groups showed significant differences (high-moderate and moderate-low values in terms of risk of recurrence were 4.66 vs 3.67 and 3.67 vs 2.88, respectively, p<0.001; high-moderate and moderate-low values in terms of risk of progression were 4.72 vs 3.68 and 3.68 vs 2.92, respectively, p<0.001). Conclusion: In our study, we found that groups with high risk of recurrence and progression had higher NLR values in patients with NMIBT. NLR, which is cheap, rapid and routinely applied in preoperative evaluation, is a promising biomarker in the prognostic classification of bladder tumors. Well-designed, large-scale prospective studies with long-term follow-up are needed to determine the role of NLR in this issue.

Authors and Affiliations

Fuat Kızılay, Adnan Şimşir

Keywords

Related Articles

The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future

Muscle invasion is present in approximately thirty percent of bladder cancers. Radical cystectomy and bilateral pelvic lymph node dissection following neoadjuvant chemotherapy is the recommended treatment for muscle inva...

Association of Preoperative De Ritis Ratio (Aspartate Amino Transferase/Alanine Amino Transferase) and Tumour Histology in Patients with Primary Bladder Cancer

Objective: De Ritis ratio, defined as the ratio of serum aspartate amino transferase (AST) and alanine amino transferase (ALT), has been demonstrated to be an independent prognostic marker in bladder cancer (BC) patients...

Comparison of Prostate Cancer Detection Rates of Cognitive Fusion-targeted Biopsy and Standard Transrectal Ultrasound-guided Biopsy

Objective: The aim of this study is to investigate whether there is a difference between standard prostate needle biopsies and cognitive fusion prostate biopsies (classical 12-core plus 2 cognitive lesions) for any prost...

Current Approach in Radiation Therapy for Prostate Cancer

Prostate cancer is one of the most common malignancies in men. Radiotherapy is one of the main treatment modalities in the treatment of prostate cancer. The reflection of technological advances in the field of radiation...

The Relationship Between the Risk of Prostate Cancer and Second to Fourth Digit Ratio

Objective: The second to fourth digit ratio is inversely related to prenatal androgen exposure, which may be a risk factor for several androgen-dependent diseases. One of these diseases is prostate cancer (PCa). Genes th...

Download PDF file
  • EP ID EP48736
  • DOI 10.4274/uob.galenos.2018.1107
  • Views 304
  • Downloads 0

How To Cite

Fuat Kızılay, Adnan Şimşir (2019). Can High Preoperative Neutrophil-lymphocyte Ratio Predict the Recurrence and Progression Risk of Nonmuscle- invasive Bladder Tumors?. The Bulletin of Urooncology, 18(2), -. https://europub.co.uk/articles/-A-48736